Ectopic expression of UBE2L3 promoted NSCLC cell growth in vitro in a cell cycle-dependent manner and NSCLC tumor growth in vivo, while knockdown of UBE2L3 significantly suppressed both in vitro and in vivo NSCLC growth [48]. The gene discussed is UBE2L3; the disease is neoplasm.